Cancer Database Query Results
adrenal, Adrenal Cancer: Click to Expand ⟱
Adrenal cancer is a rare cancer that begins in one or both of the small, triangular glands (adrenal glands) located on top of your kidneys.
|
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
adrenal, |
SK-HEP-1 |
|
|
|
- |
in-vitro, |
Liver, |
HUH7 |
|
|
|
HK2↓, PKM2↓, LDH↓, proCasp3↓, proPARP↓, Apoptosis↑, Warburg↓, Glycolysis↓, GlucoseCon↓,
| - |
in-vitro, |
adrenal, |
SK-HEP-1 |
|
|
|
- |
in-vitro, |
SCC, |
SCC4 |
|
|
|
- |
in-vitro, |
Liver, |
HUH7 |
|
|
|
- |
in-vitro, |
Cerv, |
HeLa |
|
|
|
TumCI↓, MMP9↓, uPA↓, TumCG↓, selectivity↑,
| - |
in-vitro, |
adrenal, |
H295R |
|
|
|
CYP17A1↓, CYP19↓, *Nrf1↑, *NF-kB↓, angioG↓, Apoptosis↑, AR↓, toxicity↓, BioAv↑,
*neuroP↑, *Inflam↓, *ROS↓, *BACE/β-secretase↓, *PPARγ↑, *Aβ↓, *p‑tau↓, *NF-kB↓, *IL1β↓, *IL6↓, *TNF-α↓, *ROS↓, *CREB↓, *BDNF↑, *memory↑,
| - |
in-vitro, |
adrenal, |
SK-HEP-1 |
|
|
|
TumCI↓, MMP9↓, NF-kB↓, Sp1/3/4↓, IGF-1R↓, i-ROS↓,
| - |
in-vitro, |
AML, |
HL-60 |
|
|
|
- |
in-vitro, |
adrenal, |
SK-HEP-1 |
|
|
|
Dose↝, TumCG↓, Na+↑, K+↑,
| - |
in-vitro, |
adrenal, |
PHEO |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
Apoptosis↑, ROS↑, TumCMig↓, TumCI↓, EMT↓, angioG↓, Necroptosis↑, MAPK↑, ERK↑,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
adrenal, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
*BioAv↑, *antiOx↑, *neuroP↑, *Inflam↓, *ROS↓, *H2O2↓, *GSH↑, *GPx↑, *GSR↑, *SOD↑, TumCG↓, PTEN↑, HGF/c-Met↓, PI3K↓, Akt↓, NF-kB↓, TumMeta↓, MMP2↓, MMP9↓, Ki-67↓, Casp3↑, MMP↓, H2O2↑, ROS↑, ChemoSen↑, *cardioP↑, *CDK2↓, *CDK4↓, *cycE/CCNE↓, *cycD1/CCND1↓, *RB1↓, *PCNA↓, *CREB↑, *GABA↑, *memory↑, *IGF-1↑, *ERK↑, TIMP1↑, BAX↑, Cyt‑c↑, Diablo↑, SOD2↑,
| - |
in-vitro, |
adrenal, |
ACC-M |
|
|
|
MMP9↓, NF-kB↓, IKKα↓,
Showing Research Papers: 1 to 9 of 9
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 9
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
H2O2↑, 1, ROS↑, 2, i-ROS↓, 1, SOD2↑, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
GlucoseCon↓, 1, Glycolysis↓, 1, HK2↓, 1, PKM2↓, 1, Warburg↓, 1,
Cell Death(tgid=5) ⓘ
Apoptosis↑, 3, BAX↑, 1, Casp3↑, 1, proCasp3↓, 1, Cyt‑c↑, 1, Diablo↑, 1, Necroptosis↑, 1,
Kinase & Signal Transduction(tgid=6) ⓘ
Akt↓, 1, ERK↑, 1, HGF/c-Met↓, 1, IGF-1R↓, 1, IKKα↓, 1, MAPK↑, 1, PI3K↓, 1, PTEN↑, 1, Sp1/3/4↓, 1,
DNA Damage & Repair(tgid=10) ⓘ
proPARP↓, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
Ki-67↓, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
Ki-67↓, 1, TumCG↓, 3,
Migration(tgid=13) ⓘ
EMT↓, 1, MMP2↓, 1, MMP9↓, 4, Na+↑, 1, TIMP1↑, 1, TumCI↓, 3, TumCMig↓, 1, TumMeta↓, 1, uPA↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
angioG↓, 2,
Barriers & Transport(tgid=15) ⓘ
K+↑, 1, MMP↓, 1, Na+↑, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
NF-kB↓, 3,
Hormonal & Nuclear Receptors(tgid=20) ⓘ
AR↓, 1, CYP17A1↓, 1, CYP19↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↑, 1, ChemoSen↑, 1, Dose↝, 1, selectivity↑, 1,
Clinical Biomarkers(tgid=22) ⓘ
AR↓, 1, LDH↓, 1,
Functional Outcomes(tgid=23) ⓘ
toxicity↓, 1,
Total Targets: 53
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 1, GPx↑, 1, GSH↑, 1, GSR↑, 1, H2O2↓, 1, Nrf1↑, 1, ROS↓, 3, SOD↑, 1,
Kinase & Signal Transduction(tgid=6) ⓘ
CREB↓, 1, CREB↑, 1, ERK↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
PCNA↓, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
CDK2↓, 1, CDK4↓, 1, cycD1/CCND1↓, 1, cycE/CCNE↓, 1, RB1↓, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
IGF-1↑, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
IL1β↓, 1, IL6↓, 1, Inflam↓, 2, NF-kB↓, 2, TNF-α↓, 1,
Synaptic & Neurotransmission(tgid=18) ⓘ
BDNF↑, 1, GABA↑, 1,
Protein Aggregation(tgid=19) ⓘ
Aβ↓, 1, BACE/β-secretase↓, 1, p‑tau↓, 1,
Hormonal & Nuclear Receptors(tgid=20) ⓘ
PPARγ↑, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↑, 1,
Clinical Biomarkers(tgid=22) ⓘ
IL6↓, 1,
Functional Outcomes(tgid=23) ⓘ
cardioP↑, 1, memory↑, 2, neuroP↑, 2,
Total Targets: 34
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:34 Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid
Home Page